[{"Assets_0_Q1_USD":276067000.0,"CommonStockSharesOutstanding_0_Q1_shares":346748986.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-66075000.0,"NetIncomeLoss_1_Q1_USD":-46352000.0,"StockholdersEquity_0_Q1_USD":-99369000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]